Evidence map›Paper›PMID 37636000›Full record

ArticleFrontiers in bioengineering and biotechnology2023

A novel 3D biofabrication strategy to improve cell proliferation and differentiation of human Wharton's jelly mesenchymal stromal cells for cell therapy and tissue engineering.

Cristina Blanco-Elices, Roke Iñaki Oruezabal, David Sánchez-Porras, Jesús Chato-Astrain, Fernando Campos, Miguel Alaminos, Ingrid Garzón, Antonio Campos

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Cristina Blanco-ElicesTissue Engineering Group, Department of Histology, Faculty of Medicine, Universidad de Granada, Granada, Spain.
Roke Iñaki OruezabalCentro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.
David Sánchez-PorrasTissue Engineering Group, Department of Histology, Faculty of Medicine, Universidad de Granada, Granada, Spain.
Jesús Chato-AstrainTissue Engineering Group, Department of Histology, Faculty of Medicine, Universidad de Granada, Granada, Spain.
Fernando CamposTissue Engineering Group, Department of Histology, Faculty of Medicine, Universidad de Granada, Granada, Spain.
Miguel AlaminosTissue Engineering Group, Department of Histology, Faculty of Medicine, Universidad de Granada, Granada, Spain.
Ingrid GarzónTissue Engineering Group, Department of Histology, Faculty of Medicine, Universidad de Granada, Granada, Spain.
Antonio CamposTissue Engineering Group, Department of Histology, Faculty of Medicine, Universidad de Granada, Granada, Spain.
Universidad de Granada · ESInstituto de Investigación Biosanitaria de Granada · ESSpanish National Cancer Research Centre · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biofabricationcell culturecell therapyhuman Wharton’s jelly mesenchymal stromal cellsthree-dimensionaltissue engineering

Identifiers

PMID37636000
PMCPMC10448765
OpenAlexW4385724798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.